Illumina, Inc. - Common Stock (NQ:ILMN)

276.69 +3.65 (+1.34%)

Delayed Quote Updated: 9:46 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

39 40 Next >

3 Nasdaq-100 Stocks Trading Less Than 10x 2024 Earnings

October 19, 2023

These three Nasdaq-100 stocks can be had for less than 10x 2024 earnings - extra compelling given that Wall Street expects Nasdaq profits will grow next year.

Via MarketBeat

Topics Bonds Economy

Where Illumina Stands With Analysts ↗

October 16, 2023

Via Benzinga

ChatGPT Parent OpenAI Aims At Budget-Friendly AI Innovations, Novo Nordisk's Popular Diabetes Drug Ozempic Faces Counterfeit Threat in Germany: Today's Top Stories ↗

October 12, 2023

Bloomberg Apple and Suppliers Face Unanticipated Sales Slump Despite New Launches

Via Benzinga

Topics Artificial Intelligence Supply Chain

Will Illumina Give Up Cancer Test Maker Grail? Mulls $8B Acquisition's Fate Amid Antitrust Pressure ↗

October 12, 2023

Illumina Inc (NASDAQ: ILMN) reportedly said it will divest its controversial acquisition of Grail as expeditiously as possible if the life sciences company loses either of the final appeals in U.S. or...

Via Benzinga

Expert Ratings for Illumina ↗

September 28, 2023

Via Benzinga

How Is The Market Feeling About Illumina? ↗

September 11, 2023

Via Benzinga

Is the Worst Over for Illumina Stock? ↗

September 09, 2023

There's reason to believe that the future is starting to look better.

Via The Motley Fool

$100 Invested In Illumina 20 Years Ago Would Be Worth This Much Today ↗

September 06, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 11, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 10, 2023

Via Benzinga

Bear Of The Day: Illumina ↗

October 09, 2023

Illumina, the maker of million-dollar genome sequencing machines that revolutionized the fields of genetics and biotechnology, has fallen hard in the past year.

Via Talk Markets

Illumina Faces Mounting Pressure from Regulators Over $8B Grail Acquisition ↗

October 09, 2023

The European Union regulators are set to order Illumina Inc (NASDAQ: ILMN) to divest its acquisition of

Via Benzinga

3 Undervalued Healthcare Stocks to Watch as Sector Struggles

October 06, 2023

As the healthcare sector slumps, several major stocks, including Zimmer Biomet, Moderna, and Illumina, appear undervalued in contrast to their intrinsic worth.

Via MarketBeat

11 Analysts Have This to Say About Illumina ↗

September 01, 2023

Via Benzinga

Peering Into Illumina's Recent Short Interest ↗

August 18, 2023

Via Benzinga

Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years ↗

August 17, 2023

Via Benzinga

Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors

October 04, 2023

From Lowey Dannenberg, P.C.

Via GlobeNewswire

Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors

September 29, 2023

From Lowey Dannenberg, P.C.

Via GlobeNewswire

Nike To Rally Around 53%? Here Are 10 Other Analyst Forecasts For Friday ↗

September 29, 2023

Piper Sandler cut the price target for Accenture plc (NYSE: ACN) from $312 to $300. Piper Sandler analyst Arvind Ramnani maintained a Neutral rating. Accenture shares rose 0.3% to $301.56 in pre-market...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023 ↗

September 28, 2023

Via Benzinga

September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average ↗

September 27, 2023

The September market downturn is spreading like wildfire across various sectors, with only a handful of stocks managing to maintain the positive trend seen in recent months.

Via Benzinga

Topics Stocks

Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

September 19, 2023

Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test

From Myriad Genetics, Inc.

Via GlobeNewswire

Cramer Is 'Astonished' That Chewy Is 'Doing This Poorly — So Many Of Us Use It' ↗

September 14, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said yes to The St. Joe Company (NYSE: JOE). "I’ve liked St. Joe forever," he added.

Via Benzinga

AI Integration In Biotech & Pharma: Companies Positioned To Benefit ↗

September 11, 2023

The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug discovery to patient care....

Via Benzinga

Topics Artificial Intelligence

Did Elon Musk Admit 90% Decline In Twitter's Value Since Acquisition?, Apple's Zero-Click Vulnerabilities Uncovered By Internet Watchdog Group, Gas Prices Jump As Strikes Start At Major Chevron Australia LNG Projects: Today's Top Stories ↗

September 08, 2023

Benzinga

Via Benzinga

Billionaire Activist Investor Carl Icahn Shows Support For Illumina's Newly Appointed CEO ↗

September 08, 2023

Activist investor Carl Icahn has thrown his support behind Illumina Inc's (NASDAQ: ILMN) new CEO, Jacob Thaysen, providing a sigh of relief for the company as it strives to recover from a contentious...

Via Benzinga

Cathie Wood's Buying These 3 Stocks Hand Over Fist ↗

September 08, 2023

A drugmaker, a gene sequencer, and a streaming business all made deep impressions on Ark Invest's stock-picking team.

Via The Motley Fool

Why Is Illumina Stock Trading Lower Today? ↗

September 05, 2023

Illumina Inc (NASDAQ: ILMN) shares are trading lower after the company appointed Jacob Thaysen as its new CEO, roughly three months after the company parted ways

Via Benzinga

Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor ↗

August 22, 2023

Via Benzinga

Topics Artificial Intelligence

Wall Street Thinks Illumina Stock Will Rise 27% in 1 Year. Here's Why That Probably Won't Happen. ↗

August 21, 2023

Its core revenue won't grow, and that's not even its biggest problem at the moment.

Via The Motley Fool

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.